Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)

Lipoprotein(a) [Lp(a)] is a well-established risk factor for cardiovascular disease, predisposing to major cardiovascular events, including coronary heart disease, stroke, aortic valve calcification and abdominal aortic aneurysm. Lp(a) is differentiated from other lipoprotein molecules through apoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, Constantine E., Bousvarou, Maria D., Papakonstantinou, Evangelia J., Tsamoulis, Donatos, Koulopoulos, Andreas, Echavarria Uceta, Rogers, Guzman, Eliscer, Rallidis, Loukianos S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487774/
https://www.ncbi.nlm.nih.gov/pubmed/37686428
http://dx.doi.org/10.3390/ijms241713622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487774/
https://www.ncbi.nlm.nih.gov/pubmed/37686428
http://dx.doi.org/10.3390/ijms241713622

Ejemplares similares